Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varegacestat mass balance study in healthy males
NCT06845852Phase 1Completed
- Sponsor
- Immunome
- Start
- Feb 2025
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of varegacestat, sponsored by Immunome. Primary endpoint: Mass Balance of Varegacestat at 15 days. Started Feb 2025; status: completed.
02
Drugs
varegacestat
Beyond the preview
Go deeper on NCT06845852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06845852.